Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
JIMD Reports
|
February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage
Gabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 4, 2018
The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover
Sandra Pohl, Alexandra Angermann, Anke Jeschke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 22, 2013
Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy
Allison M Bradbury, J Nicholas Cochran, Victoria J McCurdy, et al.
Blood Cells, Molecules & Diseases
|
April 28, 2019
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.
Blood Cells, Molecules & Diseases
|
April 23, 2018
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.
Journal of Lipid Research
|
January 3, 2016
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases
André R A Marques, Mina Mirzaian, Hisako Akiyama, et al.
The Journal of Clinical Investigation
|
February 4, 2014
Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker
Danielle te Vruchte, Anneliese O Speak, Kerri L Wallom, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
JIMD Reports
|
February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage
Gabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 4, 2018
The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover
Sandra Pohl, Alexandra Angermann, Anke Jeschke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 22, 2013
Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy
Allison M Bradbury, J Nicholas Cochran, Victoria J McCurdy, et al.
Blood Cells, Molecules & Diseases
|
April 28, 2019
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.
Blood Cells, Molecules & Diseases
|
April 23, 2018
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Pramod K Mistry, Manisha Balwani, Hagit N Baris, et al.
Journal of Lipid Research
|
January 3, 2016
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases
André R A Marques, Mina Mirzaian, Hisako Akiyama, et al.
The Journal of Clinical Investigation
|
February 4, 2014
Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker
Danielle te Vruchte, Anneliese O Speak, Kerri L Wallom, et al.
Page
of 12